详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse.

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, China [2]Tianjin Medical University Cancer Institute and Hospital, China [3]Department of Chemical & Pharmaceutical Engineering, College of Materials and Chemistry and Chemical Engineering, Chengdu University of Technology, No.1, East Third Road, Erxianqiao, Chengdu, Sichuan, China

出处：

DOI：

ISSN：

关键词： Honokiol Psoriasis K14-VEGF NF-kB VEGFR-2

摘要：

Honokiol (HK), a biphenolic neolignan isolated from Magnolia officinalis, has been reported to possess anti-inflammatory and anti-angiogenic activaties. In this study, our aim was to investigate anti-psoriatic activities of HK and the involved mechanisms. In vitro, the effects of HK on the regulation of Th1/Th2 and TNF-α-induced NF-κB (p65) activation were analyzed by respective FCS and immunofluorescence. Additionally, the K14-VEGF transgenic model was used for the in vivo study. ELISA and Q-PCR were performed to evaluate serum levels of Th1/Th2 cytokines and their corresponding mRNA expressions. Effects on VEGFR-2 and p65 activation, as well as other angiogenic and inflammatory parameters were studied by immunostainings. Importantly, we found that HK significantly decreased the ratio of Th1/Th2-expression CD4(+) T cells and inhibited TNF-α-induced activation of NF-κB. The morphology and histological features of psoriasis were effectively improved by HK treatment. The expression of TNF-α and IFN-γ, and their corresponding mRNA levels were down-regulated and the expression of nuclear p65, VEGFR-2, as well as related phosphorylated proteins (p-VEGFR-2, p-ERK1/2, p-AKT and p-p38) were also suppressed. Overall, these results in our study suggested that HK exhibits anti-psoriatic effects through the inhibition of NF-κB and VEGFR-2. Copyright © 2015 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2015]版：

大类 | 3 区医学

小类 | 4 区药学

最新[2023]版：

大类 | 3 区医学

小类 | 3 区药学

第一作者：

第一作者机构： [1]State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, China

共同第一作者：

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Gambogic acid exhibits anti-psoriatic efficacy through inhibition of angiogenesis and inflammation. [2]1-DNJ Alleviates Obesity-Induced Testicular Inflammation in Mice Model by Inhibiting IKKβ/ NF-kB Pathway [3]Baicalin, a Potent Inhibitor of NF-κB Signaling Pathway, Enhances Chemosensitivity of Breast Cancer Cells to Docetaxel and Inhibits Tumor Growth and Metastasis Both In Vitro and In Vivo. [4]Honokiol: A review of its pharmacological potential and therapeutic insights. [5]The application prospects of honokiol in dermatology. [6]Prokineticin 2 Plays a Pivotal Role in Psoriasis [7]Lithium-Associated Generalized Ostraceous Psoriasis Treated with Adalimumab: A Case Report [8]Atezolizumab-induced psoriasis in a patient with metastatic lung cancer-a case report [9]Enhancing the anti-glioma therapy of doxorubicin by honokiol with biodegradable self-assembling micelles through multiple evaluations. [10]Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application